MBX compared with TRVI: revenue, margins and what each company keeps, and the suppliers and customers both name

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

MBXMBX Biosciences, Inc.

TRVITrevi Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MBX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−0.55%—

May 7 '26±11.9%▲+8.06%×0.68

Q1 FY26±16.9%▼−3.42%×0.20

Jan 12 '26±17.0%▲+15.19%×0.89

TRVI

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.8%▲+0.05%×0.01

May 6 '26±8.2%▼−2.73%×0.33

= impliedMBX realized, solidTRVI realized, hatchedOne scale, both sides: full bar = 18%× = |realized| ÷ impliedSource: market data

Apr 17 '26

±17.5%

▲+4.75%

×0.27

Q1 FY26±11.9%▼−4.47%×0.38

MBXMBX Biosciences, Inc.

55.00▼−1.56%

Mkt cap$2.7B

TRVITrevi Therapeutics, Inc.

13.54▼−1.96%

Regular sessionSep 2 '83

Mkt cap$1.9B

Compare

Regular sessionSep 2 '83

MBXMBX Biosciences, Inc.

TRVITrevi Therapeutics, Inc.

55.00▼−1.56%

Price

13.54▼−1.96%

$2.7B

Mkt cap

$1.9B

MBX55.00▼−1.56%vsTRVI13.54▼−1.96%Regular sessionSep 2 '83